Essential cookies by default. The browser ID, load-time metrics and error replays only run if you choose "Accept all".
Head-to-head evidence comparison — which supplement is right for you?
Adapalene vs Tazarotene: Adapalene has the stronger overall evidence (9 vs 7.5/10); they're alternatives for clearer skin (acne) — the best pick depends on your goals. Take the 2-minute quiz for a pick tailored to your goals.
Adapalene wins 3 of 3 categories. Both are solid choices — the best pick depends on your specific goals.
Verdict
Too few graded studies
Top outcomes
Verdict
Too few graded studies
Top outcomes
Shared outcomes (2)
Outcomes where both Adapalene and Tazarotene have evidence — compare verdict strength side-by-side.
Topical use. Adapalene 0.1% (OTC) or 0.3% (prescription) gel/cream is applied as a thin layer to the whole affected area once daily, usually at night, starting every other day and building to nightly as tolerated. Full benefit takes ~8-12 weeks. There is no oral or systemic dose — it is not ingested. It is most effective combined with benzoyl peroxide. This library does not provide an ingestion protocol.
Evening
Adapalene 0.1% topical gel or cream (availability and prescription requirements depend on the country and product), applied nightly to the whole area
A source-matched dose range is not available for this product and use.
If this treatment was prescribed for you, follow your prescriber’s directions. Do not change prescribed treatment because this page has no matched dose range.
Evening
Tazarotene 0.045% lotion
Throughout
8-12 weeks
Throughout
First weeks
immediate
12 weeks
24 weeks
1-4 weeks
A comparison of the efficacy and tolerability of adapalene 0.1% gel versus tretinoin 0.025% gel in patients with acne vulgaris: a meta-analysis of five randomized trials.
Br J Dermatol (1998) · Meta-Analysis · n=900
Meta-analysis of five randomized investigator-blind trials (900 patients) in mild-to-moderate acne
Adapalene-benzoyl peroxide, a fixed-dose combination for the treatment of acne vulgaris: results of a multicenter, randomized double-blind, controlled study.
J Am Acad Dermatol (2007) · RCT · n=517
Pivotal 12-week double-blind RCT (n=517) of adapalene-BPO vs adapalene, BPO, or vehicle
Topical preparations for the treatment of mild-to-moderate acne vulgaris: systematic review and network meta-analysis.
Br J Dermatol (2021) · Systematic Review
Systematic review and network meta-analysis of 40 trials (18,089 participants) of topical acne treatments
Tazarotene 0.045% Lotion for Once-Daily Treatment of Moderate-to-Severe Acne Vulgaris: Results from Two Phase 3 Trials
J Drugs Dermatol (2020) · RCT · n=1614
The two identical phase 3 registration trials for the 0.045% lotion — 1614 subjects aged 9 and older.
New Polymeric Once-Daily Tazarotene 0.045% Lotion Formulation for Moderate-to-Severe Acne: Pooled Phase 3 Pediatric Analysis
J Drugs Dermatol (2020) · RCT · n=684
A pooled paediatric SUBGROUP analysis of the two phase 3 trials, not a separate trial: 136 patients aged 10-13 and 548 aged 14-17.
Efficacy of 0.1% tazarotene cream for the treatment of photodamage: a 12-month multicenter, randomized trial
Arch Dermatol (2002) · RCT · n=563
The long photodamage trial: 24 weeks double-blind, then a 28-week open-label extension — 12 months in total, 563 patients.
Adapalene has a higher evidence score (9/10 vs 7.5/10) and wins in 3 of 3 categories.
For clearer skin (acne), Tazarotene has a higher relevance score (88 vs 85).
No documented interaction was found in the data searched. This does not establish that this exact combination is safe.
AM/PM order, what to combine vs separate, and why sunscreen always comes first.
Bakuchiol vs retinol vs adapalene vs tretinoin — pick by strength and tolerance, not hype.
Benzoyl peroxide & retinoids → salicylic/azelaic/niacinamide → naturals, tiered by evidence.
Commonly recommended vs ask-your-clinician vs avoid — a general, safety-first overview.
The right pick depends on your goals. Answer a few quick questions for a personalised recommendation — or dig into the full evidence on each.